logo

Breaking News

Share

Symrise AG (SYIEY.PK, SYIEF.PK) said that its supervisory board once again extended the contract of Chief Executive Officer Heinz-Juergen Bertram ahead of schedule until 2025. The company noted that Bertram will continue as CEO for a further three years and will drive forward the profitable growth...

Hyundai Motor America reported that its total sales for the month of November 2021 was 44,345 units, a 20% decrease from November 2020. Hyundai eco-friendly vehicle total sales grew 165%, including November records for Nexo and Ioniq plug-in hybrid. SUV sales represented 76% of the total sales mix....

Moleculin Biotech, Inc. (MBRX) said the FDA is allowing its Investigational New Drug application to study WP1122 for the treatment of Glioblastoma Multiforme to go forward. The company plans to begin a phase 1 open label, single arm, dose escalation study of the safety, pharmacokinetics and efficacy...

Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced a positive, one-year Zuranolone 50 mg data in the ongoing open-label SHORELINE study in Patients with major depressive disorder or MDD. In the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course...

Vertex Pharmaceuticals Incorporated (VRTX) said, in a phase 2 proof-of-concept study in patients with APOL1-mediated focal segmental glomerulosclerosis, VX-147 on top of standard of care achieved a statistically significant, substantial and clinically meaningful mean reduction of 47.6% in the urine...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the launch of an authorized generic of Epiduo Forte Gel, or adapalene and benzoyl peroxide gel 0.3%/2.5%, in the U.S. It is a topical prescription medicine used to treat acne vulgaris. The company noted...

8x8, Inc. (EGHT) has entered into a definitive agreement to acquire Fuze, a provider of cloud-based communications for the enterprise. 8x8 will acquire Fuze for approximately $250 million in stock and cash. Up to $130.2 million will be used to retire Fuze's debt and pay for the equity owned by non-accredited...

SAB Biotherapeutics (SABS) said SAB-176, the company's investigational therapeutic for the treatment of seasonal influenza, achieved statistically significant reductions in viral load and clinical signs and symptoms compared to placebo in a phase 2a challenge study. SAB-176 is a quadrivalent fully...

BioXcel Therapeutics, Inc. (BTAI) said the FDA has extended the PDUFA date for its review of the New Drug Application of BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II. The company responded to the information request by FDA pertaining to analyses...

Ironwood Pharmaceuticals, Inc. (IRWD), a GI-focused healthcare company, announced Wednesday the appointment of Sravan Emany as senior vice president, chief financial officer. He will directly report to chief executive officer Thomas McCourt. Emany will become a member of Ironwood's Leadership Team...

Daktronics, Inc. (DAKT) said its second quarter operating income decreased to $4.4 million from $6.7 million, last year, due to inflation in materials and freight costs and increased personnel spend compared to prior year. Second quarter net income was $2.4 million, and earnings per share of $0.05...

Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,...

ASE Technology Holding Co., Ltd. (ASX) announced the company and Beijing Wise Road Asset Management Co. have entered into a sale and purchase agreement by which ASE will sell shares and equity interests in its subsidiaries, GAPT Holding Limited and ASE (Kun Shan) Inc., to Wise Road Capital or its designated...

Healthcare company Viatris Inc. (VTRS) announced Wednesday that the United States Court of Appeals for the Federal Circuit affirmed the June 2020 decision by the U.S. District Court for the Northern District of West Virginia invalidating Biogen's Tecfidera patent, U.S. Patent No. 8,399,514, for lack...

Philip Morris International Inc.(PM) on Wednesday said it raised earnings outlook for the full-year 2021. The company now expects full-year EPS to be in the range of $5.74 - $5.79, at prevailing exchange rates, higher than $5.77 - $5.82 previously provided. On an adjusted basis, excluding currency,...

Follow RTT